Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PORCN | Q9H237 | 2/20 | 0.42 |
| ▸ | NOS2 | P35228 | 12/20 | 0.39 |
| ▸ | CD38 | P28907 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3560162 | 1.00 | PORCN (0.42) | PORCNNOS2CD38KMT2ASMN1; SMN2 | |
| SCHEMBL3563583 | 1.00 | PORCN (0.42) | PORCNNOS2CD38KMT2ASMN1; SMN2 | |
| SCHEMBL3561824 | 0.97 | NOS2 (0.40) | PORCNNOS2CD38 | |
| SCHEMBL3561819 | 0.97 | NOS2 (0.40) | PORCNNOS2CD38 | |
| SCHEMBL3563224 | 0.81 | GAA (0.36) | NOS2CD38KMT2A | |
| SCHEMBL3558401 | 0.81 | GAA (0.36) | NOS2CD38KMT2A | |
| SCHEMBL3564868 | 0.81 | GAA (0.36) | NOS2CD38KMT2A | |
| SCHEMBL3563649 | 0.77 | CHEK1 (0.47) | PORCNNOS2CD38KMT2ASMN1; SMN2 | |
| SCHEMBL3563642 | 0.77 | CHEK1 (0.47) | PORCNNOS2CD38KMT2ASMN1; SMN2 | |
| SCHEMBL19704898 | 0.77 | NOS2 (0.57) | NOS2CD38 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7825256-B2 | Inducible nitric oxide synthase dimerization inhibitors | KALYPSYS, INC. (US) | 2010-11-02 | — | — | US | disclosed |
| US-20060116515-A1 | Inducible nitric oxide synthase dimerization inhibitors | KALYPSYS, INC. | 2006-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060116515-A1 | Inducible nitric oxide synthase dimerization inhibitors | NOS3, NOS2, NOS1 | PORCN 4110/4885NOS2 2/4885CD38 3165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.